Ruth Lydia Ladenstein

14PUBLICATIONS
205CO-AUTHORS
Haematological tumoursPredictive and prognostic markersScience, technology and engineering curriculum and pedagogyGene expression (incl. microarray and other genome-wide approaches)Epidemiological methods
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (14)

|Dec 12, 2025
Dinutuximab Beta Added to Temozolomide-Based Chemotherapy for Children With Relapsed and Refractory Neuroblastoma: Results of the ITCC-SIOPEN BEACON Immuno Phase II Trial.

Juliet C Gray, Rebekah Weston, Cormac Owens

|Aug 19, 2025
Neuroblastoma in Infants: Long-Term Survival From INES Protocols A SIOPEN Study.

Julie Savagner, Caroline Munzer, Gudrun Schleiermacher

|Jul 08, 2025
Fcγ Receptor Polymorphism in Patients with Relapsed/Refractory High-Risk Neuroblastoma Correlates with Outcomes in the SIOPEN Dinutuximab Beta Long-Term Infusion Trial.

Holger N Lode, Nikolai Siebert, Dominique Valteau-Couanet

|May 03, 2024
A human neural crest model reveals the developmental impact of neuroblastoma-associated chromosomal aberrations.

Ingrid M Saldana-Guerrero, Luis F Montano-Gutierrez, Katy Boswell

|May 02, 2024
IT-Related Barriers and Facilitators to the Implementation of a New European eHealth Solution, the Digital Survivorship Passport (SurPass Version 2.0): Semistructured Digital Survey.

Ismay A E de Beijer, Selina R van den Oever, Eliana Charalambous

|Feb 27, 2024
Comparative transcriptomics coupled to developmental grading via transgenic zebrafish reporter strains identifies conserved features in neutrophil maturation.

Stefanie Kirchberger, Mohamed R Shoeb, Daria Lazic

Pageof 3

Frequent Collaborators

5 joint publications

Pascal Chastagner

4 joint publications

Sabine Taschner-Mandl

4 joint publications

Ulrike Pötschger

4 joint publications

Adela Cañete Nieto